Fact Sheet for Healthcare Providers: Emergency Use of the VentFree Respiratory Muscle Stimulator During the COVID-19 Pandemic
Source: U.S. Food and Drug Administration (FDA). Published: 5/1/2020. This two-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the VentFree Respiratory Muscle Stimulator, which received an Emergency Use Authorization from the Food and Drug Administration on May 1, 2020, in healthcare settings for treatment of mechanically ventilated adult patients during the COVID-19 pandemic. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 1, 2020 Category: International Medicine & Public Health Source Type: news

Fact Sheet for Healthcare Providers: BioFire ® Respiratory Panel 2.1 (RP2.1) – BioFire Diagnostics, LLC
Source: U.S. Food and Drug Administration (FDA). Published: 5/1/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the BioFire ® Respiratory Panel 2.1 (RP2.1), which received an Emergency Use Authorization from the Food and Drug Administration on May 1, 2020. The BioFire® RP2.1 test is authorized for use on using respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 1, 2020 Category: International Medicine & Public Health Source Type: news

Fact Sheet for Healthcare Providers: Bio-Rad SARS-CoV-2 ddPCR Test – Bio-Rad Laboratories, Inc.
Source: U.S. Food and Drug Administration (FDA). Published: 5/1/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Bio-Rad SARS-CoV-2 ddPCR Test, which received an Emergency Use Authorization from the Food and Drug Administration on May 1, 2020. The Bio-Rad SARS-CoV-2 ddPCR Testis authorized for use on respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 1, 2020 Category: International Medicine & Public Health Source Type: news

Fact Sheet for Healthcare Providers: Emergency Use of a Protective Barrier Enclosure During the COVID-19 Pandemic
Source: U.S. Food and Drug Administration (FDA). Published: 5/1/2020. This two-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a protective barrier enclosure during the COVID-19 pandemic. The virus that causes COVID-19 is highly contagious, and the protective barrier enclosure provides an additional layer of protection when exposure to bodily fluids and airborne particles or droplets from COVID-19 patients are expected. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 1, 2020 Category: International Medicine & Public Health Source Type: news

Coordinated, National Approach to Scaling Public Health Capacity for Contact Tracing and Disease Investigation
Source: Association of State and Territorial Health Officials (ASTHO). Published: 5/2020. As the nation looks to restart the economy and recover from the COVID-19 pandemic, this 13-page document describes how reopening entirely will depend on expanded public health testing and contact tracing efforts, sustained healthcare system capacity to respond to new outbreaks, and public compliance with existing and new containment and mitigation efforts. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 1, 2020 Category: International Medicine & Public Health Source Type: news

Potential Impact of the COVID-19 Epidemic on HIV, TB and Malaria in Low- and Middle-Income Countries: Report 19
Source: Imperial College London. Published: 5/1/2020. This 29-page report aims to quantify the extent to which disruptions caused by the COVID-19 pandemic in services for HIV, TB, and malaria in high burden low- and middle-income countries could lead to additional loss of life. In high burden settings, HIV, TB, and malaria related deaths over five years may be increased by up to 10 percent, 20 percent, and 36 percent, respectively, compared to if there were no COVID-19 epidemic. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 1, 2020 Category: International Medicine & Public Health Source Type: news

COVID-19 Considerations for Cleaner Air Shelters and Cleaner Air Spaces to Protect the Public from Wildfire Smoke
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 5/1/2020. This web page provides interim guidance to reduce the risk of introducing and transmitting SARS-CoV-2 (the virus responsible for causing COVID-19) in cleaner air shelters and cleaner air spaces that are public spaces where people can seek relief from wildfire smoke. This interim guidance is intended for use by federal, state, local, and tribal jurisdictions in the United States. It should be used in conjunction with existing cleaner air shelter information, procedures, guidance, and resources. (Text) (Source: ...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 1, 2020 Category: International Medicine & Public Health Source Type: news

Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of Remdesivir (GS-5734 ™)
Source: U.S. Food and Drug Administration (FDA). Published: 5/1/2020. The Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product remdesivir for treatment of suspected or laboratory confirmed coronavirus disease 2019 (COVID-19) in adults and children hospitalized with severe disease. This 36-page fact sheet provides essential information on the use of remdesivir, an unapproved drug, to treat suspected or laboratory confirmed COVID-19. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 1, 2020 Category: International Medicine & Public Health Source Type: news

Statement on the Third Meeting of the International Health Regulations (2005) Emergency Committee Regarding the Outbreak of Coronavirus Disease (COVID-19)
Source: World Health Organization (WHO). Published: 5/1/2020. This statement summarizes the third meeting of the Emergency Committee convened by the World Health Organization (WHO) Director-General under the International Health Regulations (2005) (IHR) regarding the coronavirus disease (COVID-19), which took place on Thursday, April 30, 2020. It lists advice given to the WHO for coordination, planning, and monitoring; One Health; essential health services; risk communication and community engagement; surveillance; and travel and trade. It also lists advice given to all State Parties, including for additional health measu...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 1, 2020 Category: International Medicine & Public Health Source Type: news

COVID-19: The CIDRAP Viewpoint
Source: Center for Infectious Disease Research and Policy [University of Minnesota] (CIDRAP). Published: 4/30/2020. This two-part report discusses how we can potentially learn from past influenza pandemics as we attempt to determine a vision for the future of the COVID-19 pandemic. Identifying key similarities and differences in the epidemiology of COVID-19 and pandemic influenza can help envisioning several possible scenarios for the course of the COVID-19 pandemic. Part 2 highlights real-world examples of effective and poor COVID-19 messaging and includes recommendations. (PDF) (Source: Disaster Lit: Resource Guide for ...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 30, 2020 Category: International Medicine & Public Health Source Type: news

Operational Considerations for COVID-19 Management in the Accommodation Sector
Source: World Health Organization (WHO). Published: 4/30/2020. This eight-page document is designed to ensure that the accommodation sector can protect the health of its staff and clients from COVID-19. It is addressed to collective tourism accommodation establishments such as hotels and similar establishments, holiday and other short-stay accommodation, and campsites. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 30, 2020 Category: International Medicine & Public Health Source Type: news

Lassa Fever: Annual Epidemiological Report for 2018; Surveillance Report
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 4/30/2020. This two-page document reports that no cases of Lassa fever or other viral hemorrhagic fevers caused by arenaviruses for were reported in the European Union/European Economic Area for 2018. The report is based on data for 2018 retrieved from The European Surveillance System (TESSy) on September 10, 2019. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 30, 2020 Category: International Medicine & Public Health Source Type: news

COVID-19 in Rural America: Is There Cause for Concern?
Source: Henry J. Kaiser Family Foundation. Published: 4/30/2020. This analysis compares COVID-19 cases and deaths in metropolitan and non-metropolitan counties in the United States. It finds that while metro counties still have significantly higher cases and deaths per capita, non-metro counties are experiencing faster growth rates, potentially signaling challenges ahead. (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 30, 2020 Category: International Medicine & Public Health Source Type: news

COVID-19: The CIDRAP Viewpoint: Part 1: The Future of the COVID-19 Pandemic: Lessons Learned from Pandemic Influenza
Source: Center for Infectious Disease Research and Policy [University of Minnesota] (CIDRAP). Published: 4/30/2020. This nine-page report discusses how we can potentially learn from past influenza pandemics as we attempt to determine a vision for the future of the COVID-19 pandemic. Identifying key similarities and differences in the epidemiology of COVID-19 and pandemic influenza can help envisioning several possible scenarios for the course of the COVID-19 pandemic. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 30, 2020 Category: International Medicine & Public Health Source Type: news

Fact Sheet for Healthcare Providers: Emergency Use of multiFiltrate PRO System and multiBic/multiPlus Solutions During the COVID-19 Pandemic
Source: U.S. Food and Drug Administration (FDA). Published: 4/30/2020. This two-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Fresenius multiFiltrate PRO System and multiBic/multiPlus Solutions to provide continuous renal replacement therapy to treat patients in an acute care environment during the COVID-19 pandemic. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 30, 2020 Category: International Medicine & Public Health Source Type: news